| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $168.3M | +2.3% |
| R&D Expense | $253.6M | +27.1% |
| SG&A Expense | $53.4M | +12.4% |
| Operating Income | -$138.6M | -68.1% |
| Pre-tax Income | -$120.4M | -121.0% |
| Income Tax | $5.8M | +763.4% |
| Net Income | -$126.1M | -128.5% |
| EPS (Basic) | -$2.08 | -123.7% |
| EPS (Diluted) | -$2.08 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $53.8M | -0.3% |
| Accounts Receivable | $11.3M | -61.1% |
| Current Assets | $623.2M | -7.7% |
| Total Assets | $952.7M | +12.6% |
| Current Liabilities | $84.7M | +32.7% |
| Long-term Debt | $14.6M | — |
| Total Liabilities | $283.6M | +138.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $85.1M | +247.6% |
| Capital Expenditures | $18.4M | -52.1% |
| Investing Cash Flow | -$111.1M | +7.2% |
| Financing Cash Flow | $26.2M | +359.2% |
| Free Cash Flow | $66.7M | +575.9% |
| -123.7% |
| Stockholders' Equity |
| $668.8M |
| -8.1% |